Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03805308 · ClinicalTrials.gov registry record · NA

The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

A NA study of Ischemic Stroke, sponsored by Mercy Health Ohio.

Completed
Registry status
NA
Development phase
300
Enrollment target
20
Study locations

NCT03805308 is a NA study of Ischemic Stroke that has completed, run by Mercy Health Ohio. The registered enrollment target is 300 participants, below the 1,459-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (79% lower). The trial reports 20 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03805308, a NA study of Ischemic Stroke, has completed, sponsored by Mercy Health Ohio.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target
20
Study locations

Study Summary

The primary objective of the trial is to establish the effectiveness of IAT (versus medical management) in patients with moderate-large infarcts (NCCT ASPECTS 2-5) at baseline, with adaptive enrichment to better define the upper limit of infarct volume for treatment eligibility. Furthermore, the investigators aim to determine whether certain subgroups of patients with large baseline infarcts will have a greater treatment benefit. Finally, the investigators will assess the agreement of ASPECTS scores between site investigators, the core imaging lab, and automated software.

Conditions Studied

Ischemic Stroke

Interventions

  • PROCEDURE Intra-arterial Therapy

Study Locations (20)

California

  • PIH Health Good Samaritan Hospital and PIH Health Whittier Hospital - Los Angeles
  • Pomona Valley Hospital Medical Center - Pomona
  • Sutter Institute for Medical Research - Sacramento
  • California Pacific Medical Center & Mills Peninsula Medical Center - San Francisco
  • Los Robles Hospital and Medical Center - Thousand Oaks
  • Providence Saint John's Health Center - Torrance

Florida

  • Boca Raton Regional Hospital Inc. - Boca Raton
  • University of Miami - Coral Gables
  • Tenet Health Systems (Delray Medical Center, St. Mary's Medical Center, Palmetto General Hospital) - Delray Beach
  • Orlando Health Inc. - Orlando
  • University of South Florida - Tampa

Illinois

  • The University of Chicago - Chicago
  • Northwestern University - Evanston
  • AMITA Resurrection Medical Center and AMITA Saint Joseph Medical Center - Lisle
  • Central DuPage Hospital Association d/b/a Northwestern Medicine Central DuPage Hospital - Winfield

Indiana

  • Lutheran Medical Group - Fort Wayne
  • Munster Medical Research Foundation - Munster

Arkansas

  • Baptist Health Center for Clinical Research - Little Rock

Georgia

  • Wellstar Health System, Inc. - Marietta

Iowa

  • The University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2019-07-16
Est. Completion 2023-11-18
Phase NA

Sponsor

Mercy Health Ohio

8 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03805308

The ClinicalTrials.gov registry entry for NCT03805308 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,459-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (79% lower). The listed sponsor is Mercy Health Ohio, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Intra-arterial Therapy is the first listed.

NCT03805308 reports 20 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT03805308 about?

NCT03805308 is a clinical study titled "The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke". The primary objective of the trial is to establish the effectiveness of IAT (versus medical management) in patients with moderate-large infarcts (NCCT ASPECTS 2-5) at baseline, with adaptive enrichment to better define the upper limit of infarct volume for treatment eligibility. Furthermore, the inv...

What is the current status of trial NCT03805308?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2019-07-16. Estimated completion is 2023-11-18.

What conditions does trial NCT03805308 study?

This clinical trial studies the following conditions: Ischemic Stroke.

What interventions are being tested in trial NCT03805308?

The interventions under investigation include: Intra-arterial Therapy (PROCEDURE).

Who is sponsoring clinical trial NCT03805308?

This trial is sponsored by Mercy Health Ohio, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03805308 being conducted?

This trial has 20 study locations across Arkansas, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ischemic Stroke

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.